Tandem Diabetes Care to Hold Virtual-Only 2020 Annual Meeting of Stockholders
May 18 2020 - 4:15PM
Business Wire
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin
delivery and diabetes technology company, today announced that its
2020 Annual Meeting of Stockholders (“Annual Meeting”) will be held
in a virtual-only format due to continued public health concerns
relating to COVID-19 and to prioritize the health and well-being of
meeting participants. There is no change to the previously
announced date and time of the meeting, which will be held on May
27, 2020 at 3:00pm Pacific Daylight Time.
Stockholders at the close of business on the record date, March
31, 2020, are entitled to participate in the Annual Meeting. To be
admitted to the Annual Meeting at
https://web.lumiagm.com/235916184, stockholders must enter the
password “tandem2020” and the control number previously received on
their proxy card. Once admitted to the Annual Meeting, stockholders
who entered with a control number will be able to ask questions and
vote during the Annual Meeting by following the instructions on the
Annual Meeting website. Persons without a control number may enter
the meeting as a guest, but may not ask questions or vote.
Stockholders who are “beneficial owners” and hold their shares
through a broker, bank or other agent and who want to participate
and vote at the virtual Annual Meeting, must obtain a valid legal
proxy from their broker, bank or other agent and then register in
advance to attend the Annual Meeting through our transfer agent,
American Stock Transfer & Trust Company LLC, no later than 5:00
p.m. Eastern Time, on May 22, 2020. Directions for registering and
voting can be found in the Notice of Change in Location of the 2020
Annual Meeting of Stockholders and other proxy materials filed with
the U.S. Securities Exchange Commission and also posted to the
Company’s website at www.tandemdiabetes.com by clicking on
“Investor Center” and then “Stockholder Meetings.”
Whether or not stockholders plan to attend the virtual-only
Annual Meeting, Tandem Diabetes Care encourages all stockholders to
vote and submit their proxies in advance of the Annual Meeting by
one of the methods described in the proxy materials previously
provided.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical
device company dedicated to improving the lives of people with
diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach
to the design, development and commercialization of products for
people with diabetes who use insulin. Tandem’s flagship product,
the t:slim X2™ insulin pump, is capable of remote software updates
using a personal computer and features integrated continuous
glucose monitoring. Tandem is based in San Diego, California.
Tandem Diabetes Care is a registered trademark and t:slim X2 is
a trademark of Tandem Diabetes Care, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200518005711/en/
Media Contact: Steve Sabicer 714-907-6264
ssabicer@thesabicergroup.com
Investor Contact: Susan Morrison 858-366-6900 x7005
IR@tandemdiabetes.com
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From Apr 2023 to Apr 2024